Search All News
Seizures are usually considered a side effect of brain cancer, but a new Columbia University study of mice suggests they may also fuel the further growth of brain tumors.
Scientists at Columbia's Herbert Irving Comprehensive Cancer Center are using technologies developed to study cancer to look for drugs to treat COVID-19 and disarm the virus.
In a new study of mice, Columbia researchers found that an experimental drug that breaks down an amino acid slows pancreatic tumor growth by causing ferroptosis, an unusual form of cell death.
- June 6, 2013
Dr. Ravi P. Kiran has been named chief and program director of the Division of Colorectal Surgery at NewYork-Presbyterian/Columbia University Medical Center.
- May 20, 2013
New computational tool translates complex data into 2-dimensional images; may allow doctors to track cancer progression.
- May 16, 2013
Columbia licenses 3-D organ and tumor imaging software that aids in planning cancer surgeries and radiation treatments to Varian Medical Systems.
- May 16, 2013
Dr. Robert Klitzman applauded Jolie's prophylactic breast cancer surgery but says it raises moral questions about gene patents.
- May 3, 2013
The first event in a series of public lectures at CUMC updated community residents about new research on leukemia.
- April 23, 2013
A study from Columbia University’s Mailman School of Public Health is one of the first assessments of the link between obesity and precancerous abnormalities in biopsy tissue samples.
- April 21, 2013
A massive study analyzing gene expression data from 22 tumor types has identified multiple metabolic expression changes associated with cancer.
- March 5, 2013
Scientists discovered how common genetic mutations in Parkinson’s disease damage brain cells
- February 28, 2013
“This study is one of the first to evaluate the course of PTSD after a diagnosis of breast cancer,” said lead author, CUMC's Dr. Alfred Neugut.